Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR StudyTarget Oncol 2022 Jun 25;[EPub Ahead of Print], M Maruzzo, F Pierantoni, A Bortolami, D Palleschi, A Zivi, M Nicodemo, D Sartori, R De Vivo, F Zustovich, D Bimbatti, D Pastorelli, GD Vultaggio, M Soraru', M Ballestrin, C Modonesi, P Randisi, C Barile, G Perri, U Basso, V Zagonel
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.